Cargando…
Vaccines for type 1 diabetes in the late stage of clinical development
Autor principal: | Gupta, Sandeep K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153725/ https://www.ncbi.nlm.nih.gov/pubmed/21845017 http://dx.doi.org/10.4103/0253-7613.83130 |
Ejemplares similares
-
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
por: Sasaki, Hironobu, et al.
Publicado: (2022) -
Fulminant type 1 diabetes after COVID-19 vaccination
por: Tang, Xiaohan, et al.
Publicado: (2022) -
The need to develop and sustain a symbiotic relationship between the industry and academia in the field of clinical pharmacology in India
por: Gupta, Sandeep Kumar
Publicado: (2011) -
Comments on: Does myopia decrease the risk of diabetic retinopathy in both type-1 and type-2 diabetes mellitus?
por: Chaurasiya, Ritesh Kumar, et al.
Publicado: (2023) -
BCG Vaccination Status and its Relationship to Islet Autoantibodies in Children with Type 1 Diabetes
por: Rohilla, Latika, et al.
Publicado: (2021)